For patients who have undergone significant weight loss, a panniculectomy—the surgical removal of excess, sagging abdominal skin—can be a life-changing procedure. Often performed to alleviate chronic rashes, skin infections, and mobility limitations, this surgery is a cornerstone of reconstructive plastic surgery. However, new research published in the November issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS), suggests that patients with a history of COVID-19 may face a previously unrecognized hurdle: a significantly higher risk of life-threatening blood clots.
This finding adds a new layer of complexity to preoperative planning, suggesting that the lingering physiological impacts of the SARS-CoV-2 virus may extend well into the operating room long after the initial infection has cleared.
The Core Findings: A Closer Look at VTE Risk
Venous thromboembolism (VTE) is a serious, potentially fatal complication characterized by the formation of blood clots, most commonly as deep vein thrombosis (DVT) in the legs or pulmonary embolism (PE) in the lungs. In the context of major surgeries, such as body contouring, managing this risk is a top priority for surgical teams.
According to the study, titled "Incidence of Postoperative Venous Thromboembolism following Panniculectomy in Patients with History of COVID-19," researchers analyzed data from over 7,000 patients who underwent panniculectomy procedures between 2017 and 2023. While general VTE rates remained relatively stable before and after the onset of the pandemic, a deeper dive into the data revealed a stark discrepancy when isolating patients with a documented history of COVID-19.
Patients who had previously contracted the virus were found to have a VTE incidence rate of 4.9%, compared to just 2.5% in patients who had never tested positive for COVID-19. This discovery suggests that a prior COVID diagnosis may act as an independent, predisposing risk factor for clotting complications, complicating the standard risk-assessment protocols currently used in clinical practice.
Chronology: Understanding the Surgical Landscape
To understand the scope of the researchers’ findings, it is helpful to view the study within the timeline of the COVID-19 pandemic and its impact on elective surgical care.
2017–2019: The Pre-Pandemic Baseline
Prior to 2020, the standard of care for panniculectomy patients involved the use of the "Caprini score," a validated risk-assessment tool that helps surgeons determine a patient’s susceptibility to VTE. Based on this score, patients are prescribed specific prophylactic treatments, such as anticoagulants (blood thinners), to prevent clots during and after surgery. During this era, the baseline risk for VTE was well-understood and managed through these established protocols.
2020–2021: The Pandemic Shift
As the COVID-19 pandemic took hold, surgical departments worldwide faced unprecedented challenges. Elective surgeries were frequently paused, and when they resumed, the medical community began to notice unique systemic effects of the virus. Early anecdotal evidence and subsequent research highlighted that COVID-19 was not just a respiratory illness but a systemic one, frequently causing a "hypercoagulable state"—a condition where the blood is more prone to clotting than usual.
2022–2023: Emerging Data and Analysis
As elective surgeries returned to pre-pandemic volumes, researchers began to collect enough data to assess whether the hypercoagulability associated with COVID-19 was translating into higher complication rates for surgical patients. The study led by medical student Mary Newland and her colleagues at Penn State College of Medicine is a direct result of this retrospective effort, bridging the gap between historical surgical standards and the "new normal" of post-pandemic patient physiology.
Supporting Data: Why the Numbers Matter
The strength of the study lies in its robust sample size. The researchers examined data from 7,114 patients, providing a clear window into how the pandemic era shifted outcomes.
Comparative Group Analysis
- Total Patients: 7,114
- Pre-Pandemic Group (2017–2020): 3,015 patients. The VTE rate in this group was 3.2%.
- Post-Pandemic Group (2020–2023): 4,099 patients. The VTE rate in this group was 3.0%.
At first glance, these numbers suggest that the pandemic did not increase the overall risk of VTE for the average surgical patient. However, when the researchers isolated the 4,099 post-pandemic patients and compared those with a history of COVID-19 (790 patients) to those without (3,309 patients), the true impact became clear:
- COVID-Positive History: 4.9% VTE rate.
- COVID-Negative History: 2.5% VTE rate.
Eliminating Confounding Variables
Critics of such studies often ask if the increased risk is simply due to other underlying conditions, such as heart disease or blood vessel disorders. In this study, the researchers carefully accounted for these comorbidities. They found that other potential risk factors for VTE were statistically similar between the two groups, strengthening the argument that the history of COVID-19 itself was the primary driver of the increased clot risk.
Official Responses and Clinical Perspectives
Lead author Mary Newland, BS, emphasizes the importance of these findings for the future of plastic surgery. "Our findings suggest that past COVID may be an additional predisposing risk factor for VTE among patients undergoing panniculectomy," Newland stated. "This may have implications for assessment and prevention of surgical risks of body contouring surgery after major weight loss."
The medical community has reacted with cautious interest. While the study does not suggest that patients with a history of COVID-19 should avoid surgery altogether, it does advocate for a more nuanced approach to preoperative screening. Surgeons are being urged to consider whether a history of COVID-19 should effectively "boost" a patient’s risk category, perhaps necessitating more aggressive anticoagulant therapy or extended monitoring post-surgery.
The authors conclude that these results demonstrate the emergence of a "new patient population" who may be more susceptible to postoperative complications. They emphasize that while this study is a vital first step, further clinical research is required to standardize how plastic surgeons incorporate a patient’s COVID history into their risk-assessment tools.
Implications for Patients and Surgeons
The implications of this research are twofold: they affect how surgeons prepare for surgery and how patients engage in the informed consent process.
For Surgeons: Updating the "Caprini" Approach
The Caprini score is a gold standard, but it is not static. It evolves as we learn more about human physiology. The inclusion of a "COVID-19 History" field in preoperative screening could become a standard requirement. Surgeons may need to weigh the benefits of a panniculectomy against the heightened risk of VTE, particularly for patients who had severe COVID infections or long-haul symptoms.
For Patients: Transparency and Communication
Patients considering body contouring after significant weight loss must be transparent with their surgical team regarding their health history. If you have had COVID-19, regardless of how mild the case was, it is critical to disclose this information to your surgeon. Patients should feel empowered to ask their surgical team, "How does my history of COVID-19 affect my risk of blood clots, and what measures will you take to mitigate that risk?"
The Path Forward
The medical community is still uncovering the long-term effects of the SARS-CoV-2 virus. As we move further into the post-pandemic era, studies like the one presented in Plastic and Reconstructive Surgery are essential for refining patient care. By identifying these hidden risks, surgeons can provide safer, more tailored care, ensuring that life-changing procedures remain as safe as possible.
As the authors note, while the data is compelling, it is a call for further study. Future research will likely focus on the timing of the infection—whether a COVID infection in the last three months carries a higher risk than one from two years ago—and whether vaccination status or the severity of the initial illness influences post-surgical clotting risks.
For now, the message to both clinicians and patients is clear: vigilance remains our greatest tool. As we navigate the complex landscape of post-pandemic medicine, keeping an eye on the subtle, long-term impacts of the virus is vital to protecting patient safety in the operating room.
For more information on the latest research in plastic and reconstructive surgery, visit the official journals of the American Society of Plastic Surgeons at journals.lww.com/plasreconsurg.
Article Reference: "Incidence of Postoperative Venous Thromboembolism following Panniculectomy in Patients with History of COVID-19" (doi: 10.1097/PRS.0000000000012202)
About the Author
